DEUTSCHE BANK AG\
BankPosition in APLS — Apellis Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in APLS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$0
+$0 QoQ
Shares Held
95,365
-93.1% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in APLS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 95,365 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | — | 1,385,263 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | — | 1,504,457 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | — | 1,496,296 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | — | 1,776,576 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | — | 1,778,377 | Shares | Sole | 2025-06-30 | |
| 2024-09-30 | — | 1,747,510 | Shares | Sole | 2025-06-26 | |
| 2024-06-30 | — | 1,842,042 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | — | 1,611,773 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | — | 856,999 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | — | 324,294 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | — | 478,366 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | — | 599,428 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | — | 263,177 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | — | 567,745 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | — | 694,607 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | — | 544,311 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | — | 338,753 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | — | 291,009 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | — | 319,961 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | — | 419,660 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | — | 633,737 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | — | 557,231 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | — | 545,087 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | — | 185,442 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||